Pathstone Family Office’s Cognition Therapeutics CGTX Stock Holding History

Pathstone Family Office’s Portfolio CGTX Stock Details CGTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$3.18M	Hold
2023 Q2	$4.04M	Sell
2023 Q1	$4.38M	Sell
2022 Q4	$212	Hold
2022 Q3	$8.4M	Buy
2022 Q2	$4.66M	Buy